| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2138340 | Leukemia Research | 2009 | 4 Pages |
Abstract
The occurrence of multiple myeloma and chronic lymphocytic leukemia in the same patient is very uncommon. The immunomodulatory agent lenalidomide has been shown to have high response rates in multiple myeloma and appears to be quite active in advanced CLL. We report two patients with concurrent CLL and MM who were both treated successfully with lenalidomide.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Sridhar Srinivasan, Charles A. Schiffer,